Despite interest in HLA-E and CD94/NKG2x for infectious disease and cancer treatment, a limited number of HLA-E peptide binders are currently known, with approximately 700 total contained in the Immune Epitope Database (IEDB)24, but likely do not represent a systematic assessment of all possible HLA-E binders. Here, HLA-E is linked to cancer.